Showcasing at AAO 2025: NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography…
Nine-month 2025 revenue of €8.7 million, up +36% compared to the same period last year U.S. activity up +22% in…
Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission Positive ENLIGHTEN 2 results…
The Company expects to reestablish and announce a new record date as soon as possibleALAMEDA, Calif., Oct. 03, 2025 (GLOBE…
IRVINE, Calif., Oct. 1, 2025 /PRNewswire/ -- Overture Orthopaedics, a privately held U.S.-based medical device company providing surgeons with innovative…
iTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to…
Fewer than 5% of eligible patients worldwide receive cochlear implants todayHearing loss is the largest modifiable risk factor for dementia,…
Strengthening the commercialization strategy for cobotic1 solutions in orthopedic surgeryBORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168,…
Strengthening the commercialization strategy for cobotic1 solutions in orthopedic surgeryBORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168,…
- Patent portfolio secures innovation for the future of heart replacement - TUCSON, Ariz., Sept. 22, 2025 (GLOBE NEWSWIRE) --…